Cohen & Steers’s DexCom DXCM Stock Holding History

Cohen & Steers’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,416	Closed	-$911K	–	397
2019 Q3	$911K	Hold	24,416	–	–	﹤0.01%	314
2019 Q2	$915K	Buy	+24,416	New	+$767K	﹤0.01%	325

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Cohen & Steers's DXCM Position: Q4 2019 in Review

Cohen & Steers sold out of DexCom (DXCM) in Q4 2019, closing a stake of 24,416 shares — an estimated $911K sold.

Cohen & Steers first reported a position in DXCM in Q2 2019 and held it in 2 quarters. The position peaked at $915K in Q2 2019. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

Cohen & Steers reported no remaining DexCom position as of Q4 2019 after selling out during the quarter.
Cohen & Steers sold 24,416 DexCom shares in Q4 2019, an estimated $911K.
Cohen & Steers first reported a position in DexCom in Q2 2019 and held it in 2 quarters.
Cohen & Steers's DexCom position peaked at $915K in Q2 2019.
509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Cohen & Steers's 13F filing for Q4 2019, filed 14 Feb 2020.